“SMART” Drug Delivery Systems: Double-Targeted pH-Responsive Pharmaceutical Nanocarriers
Top Cited Papers
- 30 June 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 17 (4) , 943-949
- https://doi.org/10.1021/bc060080h
Abstract
To develop targeted pharmaceutical carriers additionally capable of responding to certain local stimuli, such as decreased pH values in tumors or infarcts, targeted long-circulating PEGylated liposomes and PEG-phosphatidylethanolamine (PEG-PE)-based micelles have been prepared with several functions. First, they are capable of targeting a specific cell or organ by attaching the monoclonal antimyosin antibody 2G4 to their surface via pNP-PEG-PE moieties. Second, these liposomes and micelles were additionally modified with biotin or TAT peptide (TATp) moieties attached to the surface of the nanocarrier by using biotin-PE or TATp-PE or TATp-short PEG-PE derivatives. PEG-PE used for liposome surface modification or for micelle preparation was made degradable by inserting the pH-sensitive hydrazone bond between PEG and PE (PEG-Hz-PE). Under normal pH values, biotin and TATp functions on the surface of nanocarriers were “shielded” by long protecting PEG chains (pH-degradable PEG2000-PE or PEG5000-PE) or by even longer pNP-PEG-PE moieties used to attach antibodies to the nanocarrier (non-pH-degradable PEG3400-PE or PEG5000-PE). At pH 7.4−8.0, both liposomes and micelles demonstrated high specific binding with 2G4 antibody substrate, myosin, but very limited binding on an avidin column (biotin-containing nanocarriers) or internalization by NIH/3T3 or U-87 cells (TATp-containing nanocarriers). However, upon brief incubation (15−30 min) at lower pH values (pH 5.0−6.0), nanocarriers lost their protective PEG shell because of acidic hydrolysis of PEG-Hz-PE and acquired the ability to become strongly retained on an avidin column (biotin-containing nanocarriers) or effectively internalized by cells via TATp moieties (TATp-containing nanocarriers). We consider this result as the first step in the development of multifunctional stimuli-sensitive pharmaceutical nanocarriers.Keywords
This publication has 33 references indexed in Scilit:
- Recent advances in tumor-targeting anticancer drug conjugatesBioorganic & Medicinal Chemistry, 2005
- Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptidesAdvanced Drug Delivery Reviews, 2005
- Recent advances with liposomes as pharmaceutical carriersNature Reviews Drug Discovery, 2005
- Drug delivery of oligonucleotides by peptidesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2004
- Oligomers of the Arginine-rich Motif of the HIV-1 TAT Protein Are Capable of Transferring Plasmid DNA into CellsJournal of Biological Chemistry, 2003
- Efficiency of Protein Transduction Is Cell Type-dependent and Is Enhanced by Dextran SulfateJournal of Biological Chemistry, 2002
- Differential Conjugation of Tat Peptide to Superparamagnetic Nanoparticles and Its Effect on Cellular UptakeBioconjugate Chemistry, 2002
- In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the MouseScience, 1999
- Intracellular Regulation of Macromolecules Using pH-Sensitive Liposomes and Nuclear Localization Signal: Qualitative and Quantitative Evaluation of Intracellular TraffickingBiochemical and Biophysical Research Communications, 1998
- The mechanism of liposome accumulation in infarctionBiochimica et Biophysica Acta (BBA) - General Subjects, 1984